Asa Biopharm's Podcast
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 73:06:24
- Mais informações
Informações:
Sinopse
In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.
Episódios
-
Episode 87: Storytelling
31/03/2021 Duração: 01h04minScott Evans, Stephanie Omokaro, Janet Wittes, and Zhiheng Xu discuss the importance of storytelling for the modern statistician.
-
Episode 86: Pediatric Drug Development Scientific Working Group
25/02/2021 Duração: 47minMeg Gamalo and Jingjing Ye talk about pediatric drug development and discuss why forming a scientific working group was so important.
-
Episode 85: Weili He
29/01/2021 Duração: 40minWeili talks about publishing, leadership, and her hopes and plans for the Biopharmaceutical Section in 2021.
-
Episode 84: David Salsburg
01/01/2021 Duração: 46minDavid shares some of his experiences as the first statistician ever hired at Pfizer.
-
Episode 83: Vaccine Development
30/11/2020 Duração: 35minKerry Go and Elaine Hoffman discuss vaccine development.
-
Episode 82: Olga Marchenko and Natallia Katenka
30/10/2020 Duração: 49minOlga and Natallia discuss their new book Quantitative Methods in Pharmaceutical Research and Development: Concepts and Applications.
-
Episode 81: Mentor-Mentee Pairs from the BIOP Mentoring Program
30/09/2020 Duração: 01h42minThis episode features discussions with 3 mentor-mentee pairs from the Biopharmaceutical Section mentoring program. Conversations include Qing Li and Abie Ekangaki (start 1:25), Samson Ghebremariam and Scott Clark (start 44:33), and Carie Kimbrough and Bruce Binkowitz (start 102:29). They discuss the benefits of mentoring and the dynamics of the mentoring relationship.
-
Episode 80: 2020 Regulatory-Industry Statistics Workshop
31/08/2020 Duração: 47minYabing Mai and Thomas Birkner discuss the 2020 Workshop and the changes necessary to go virtual.
-
Episode 79: Nusrat Rabbee
31/07/2020 Duração: 01h07minNusrat discusses biomarker analysis throughout clinical development and her recent book Biomarker Analysis in Clinical Trials with R.
-
Episode 78: Challenges with Pain Assessments
30/06/2020 Duração: 54minDottie Brown, Ciprian Crainiceanu, and Jean Recta discuss how pain is quantified in human and animal trials.
-
Episode 77: National Institute of Statistical Sciences
29/05/2020 Duração: 54minNancy Flournoy, Dan Holder, and Jim Rosenberger discuss the mission and history of the National Institute of Statistical Sciences and how it will adapt for the future.
-
Episode 76: COVID-19 and Clinical Trials
15/04/2020 Duração: 46minMouna Akacha, Yongming Qu, and Aileen Ward discuss COVID-19 and the operational and statistical effects on clinical trials.
-
Episode 75: Meijuan Li
31/03/2020 Duração: 52minMeijuan Li discusses precision medicine, diagnostic devices, and the importance of parallel development of drugs and diagnostics.
-
Episode 74: Glen Colopy and the Pod of Asclepius
28/02/2020 Duração: 47minGlen discusses his graduate training in data science in the United Kingdom, vital sign monitoring, the challenges of efficient drug supply, and his healthcare technology podcast, the Pod of Asclepius.
-
Episode 73: Bruce Binkowitz
03/02/2020 Duração: 44minBruce discusses the Japanese regulatory environment, challenges for statistics departments spread across the globe, and his hopes and plans for the Biopharmaceutical Section in 2020.
-
Episode 72: Abie Ekangaki
31/12/2019 Duração: 56minAbie discusses opportunities for statisticians in the CRO industry, and we chat about the Scholarship and Leadership-in-Practice Committees of the Biopharmaceutical Section.
-
Episode 71: P-values in Medical Product Development
02/12/2019 Duração: 59minLisa LaVange, J. Jack Lee, and Steve Ruberg about the ASA Statement on p-values, and their recent paper entitled “Inference and Decision Making for 21st-Century Drug Development and Approval” which was featured in the American Statistician in early 2019.
-
Episode 70: 2020 International Conference on Health Policy Statistics
31/10/2019 Duração: 45minKate Crespi and Ofer Harel discuss the 2020 International Conference on Health Policy Statistics, and describe current topics of interest in health policy including gun violence and opioids.
-
Episode 69: Non-proportional Hazards
30/09/2019 Duração: 50minKeaven Anderson, Pralay Mukhopadhyay, and Satrajit Roychoudhury discuss non-proportional hazards in a regulatory setting.
-
Episode 68: 2019 Regulatory-Industry Statistics Workshop
30/08/2019 Duração: 44minJudy Li and Renee Rees discuss what's new and exciting at the 2019 Regulatory-Industry Statistics Workshop.